ConCallIQ
Go Pro

Coromandel International FY26 Annual Earnings Summary

3 quarters covered · ₹24,638 Cr revenue · ₹1,396 Cr PAT · 2.7% average EBITDA margin.

Total annual revenue: ₹24,638 Cr
Annual PAT: ₹1,396 Cr
Average margin: 2.7%
Promise delivery: Building

Quarter-by-quarter progression

QuarterRevenuePATMarginSentiment
Q2 FY26₹9,771 Cr₹793 Crbullish
Q3 FY26₹8,863 Cr₹488 Crneutral
Q4 FY26₹6,004 Cr₹115 Cr8.0%neutral

Management promises made during the year

Promise tracking available after 2+ quarters of coverage.

Risks flagged during the year

Q3 FY26 · high

Sulfur prices have surged to $550/ton from $180-200, impacting input costs. Management expects moderation but uncertainty remains.

Q4 FY26 · high

Ammonia and sulfur prices surged ~$840/ton and ~$800/ton respectively, while NBS rates increased only 10%. Government may not provide timely additional subsidy, compressing H1 margins.

Q4 FY26 · high

80%+ of ammonia and sulfur imports transit via the Strait of Hormuz; ongoing crisis threatens Q2 availability and keeps prices elevated.

Q2 FY26 · medium

Spike in ammonia and sulfur during Q2 impacted production; management expects softening but uncertainty remains.

Q2 FY26 · medium

Prototype evaluation by government has taken longer than expected; management acknowledged delay but no clear timeline for first order.

Q3 FY26 · medium

Current NBS rates may not fully compensate for higher raw material costs and rupee depreciation, pressuring fertilizer margins.

Q3 FY26 · medium

NCL's margins remain muted due to lower capacity utilization at hedge facilities; full synergy benefits may take longer.

Q4 FY26 · medium

₹71 crore impairment taken on Daksha investment due to order execution delays; management is personally driving recovery but no near-term revenue visibility.

Q2 FY26 · low

NACL's lower margin profile (9-11% vs Coromandel's 17-18%) and one-time exceptional items impacted consolidated crop protection margins.

Q2 FY26 · low

Excess rains in August-September affected crop input application and specialty product sales, though rabi outlook is positive.

Q3 FY26 · low

Consumption-based market share moderated to 14% in Q3 from 15% last year due to lower offtake in southern states.

Q4 FY26 · low

Despite 60% volume growth, adoption remains slow without policy intervention; farmers continue to prefer subsidized urea and DAP.

What changed through the year

G

Q2 FY26 · Kakinada phosphoric/sulfuric acid plant commissioning in January 2026

Mechanical completion expected in December 2025, trial runs in January, commercial production by mid-January. Plant will generate power for entire complex and reduce cost profile.

G

Q2 FY26 · NPK capacity expansion to 1 million tons at Kakinada by Q3 FY27

Project progressing well; will support volume growth in northern and central India.

G

Q2 FY26 · Domestic formulation business to grow 25% in FY26

Driven by new product launches, territory expansion, and co-marketing agreements. Targeting ₹1,000 crore revenue for formulation business.

G

Q2 FY26 · Minimum EBITDA of ₹5,500/ton for fertilizers in H2

Management confident of sustaining this level despite raw material volatility.

G

Q3 FY26 · Fertilizer EBITDA margin target of ₹5,000-5,500/ton annualized

Management reiterated the annualized EBITDA margin target of ₹5,000-5,500 per ton for the fertilizer business, despite near-term pressure from higher sulfur prices and currency depreciation.

G

Q3 FY26 · Backward integration projects at Kakinada to commission this quarter

The sulfuric acid and phosphoric acid plants at Kakinada are progressing as per timelines and will be commissioned during Q4 FY26.

G

Q3 FY26 · Granulation train expansion to commission in Q3 FY27

The granulation train expansion is on track and will be commissioned in the third quarter of FY27.

G

Q3 FY26 · Crop protection domestic B2C growth target of 20-25% annually

Management aims to grow the domestic branded formulation business by 20-25% year-on-year, supported by new product launches and market expansion.

G

Q4 FY26 · Crop protection revenue growth 20-25% in FY27

Driven by new product launches (6 new products), capacity expansion for key molecule, and aggressive domestic formulation growth.

G

Q4 FY26 · Crop protection consolidated EBITDA margin to stabilize at 9-10%

NACL integration and product portfolio changes expected to improve margins from current 6-7%.

G

Q4 FY26 · Granulation capacity expansion commissioning by December 2026

Project to expand granulation capacity is on track for commissioning by December of this financial year.

G

Q4 FY26 · Senegal mine output to increase 30-40% in FY27

Planned volume increase from 3.5 lakh tons to support backward integration.